<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00587756</url>
  </required_header>
  <id_info>
    <org_study_id>MTX-1STAGE</org_study_id>
    <secondary_id>MTX-CRC-1STAGE</secondary_id>
    <nct_id>NCT00587756</nct_id>
  </id_info>
  <brief_title>Alternative to Two-Stage Hepatectomy</brief_title>
  <official_title>One-Stage Ultrasound-Guided Hepatectomy for Multiple Bilobar Colorectal Metastases: a Feasible and Effective Alternative to Two-Stage Hepatectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Milan</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondazione Humanitas per la Ricerca</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Milan</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Two-stage hepatectomy with or without portal vein embolization allows to treat multiple
      bilobar metastases expanding surgical indications for these patients. However, it has some
      related drawbacks: two operations are needed, and some patients do not complete the treatment
      strategy for disease progression. Using experience gained from our ultrasound guided
      resection policy we explored the safety and effectiveness of one-stage surgical procedures in
      patients otherwise recommended for the two-stage approach.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2001</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">May 2007</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The primary outcome was the safety of the procedure. To this purpose we studied morbidity, mortality, amount of blood loss, rate of blood transfusions, and postoperative trend of liver function tests.</measure>
    <time_frame>30-day and 90-day postoperatively</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The secondary outcome measure was the reliability of the procedure from an oncological standpoint. For this purpose we studied the rate of true local recurrence (cut-edge) after a minimum follow-up of 6 months.</measure>
    <time_frame>Minimum Follow-up of 6 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">19</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>Liver Metastases</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Prospective cohort of consecutive patients who undergo surgery for colorectal cancer liver metastases</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>One-stage ultrasound guided hepatectomy</intervention_name>
    <description>Surgical strategy was based on tumor-vessel relationship at intraoperative ultrasonography (IOUS)and on findings at color-Doppler IOUS.</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients carriers of colorectal cancer liver metastases
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patients presenting with resectable colorectal cancer liver metastases (CLM)

          2. 4 or more lesions

          3. Bilobar involvement of the liver

          4. Contact or close adjacency (less than 0.5 cm) of at least one CLM with major
             intrahepatic vascular structures (1st or 2nd order portal branches and/or hepatic vein
             at caval confluence).

        Exclusion Criteria:

          1. Patients with 3 or less resectable CLM

          2. Patients with 4 or more resectable CLM but nor bilobar

          3. Patients with 4 or more bilobar resectable CLM without any lesion presenting condition
             of point 4 of the inclusion criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Guido Torzilli, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Milan, Istituto Clinico Humanitas - IRCCS</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Istituto Clinico Humanitas - Irccs</name>
      <address>
        <city>Rozzano - Milano</city>
        <zip>20089</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Adam R, Laurent A, Azoulay D, Castaing D, Bismuth H. Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors. Ann Surg. 2000 Dec;232(6):777-85.</citation>
    <PMID>11088072</PMID>
  </reference>
  <reference>
    <citation>Jaeck D, Oussoultzoglou E, Rosso E, Greget M, Weber JC, Bachellier P. A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases. Ann Surg. 2004 Dec;240(6):1037-49; discussion 1049-51.</citation>
    <PMID>15570209</PMID>
  </reference>
  <reference>
    <citation>Torzilli G, Montorsi M, Donadon M, Palmisano A, Del Fabbro D, Gambetti A, Olivari N, Makuuchi M. &quot;Radical but conservative&quot; is the main goal for ultrasonography-guided liver resection: prospective validation of this approach. J Am Coll Surg. 2005 Oct;201(4):517-28.</citation>
    <PMID>16183489</PMID>
  </reference>
  <reference>
    <citation>Torzilli G, Montorsi M, Del Fabbro D, Palmisano A, Donadon M, Makuuchi M. Ultrasonographically guided surgical approach to liver tumours involving the hepatic veins close to the caval confluence. Br J Surg. 2006 Oct;93(10):1238-46.</citation>
    <PMID>16953487</PMID>
  </reference>
  <reference>
    <citation>Torzilli G, Del Fabbro D, Palmisano A, Donadon M, Bianchi P, Roncalli M, Balzarini L, Montorsi M. Contrast-enhanced intraoperative ultrasonography during hepatectomies for colorectal cancer liver metastases. J Gastrointest Surg. 2005 Nov;9(8):1148-53; discussion 1153-4.</citation>
    <PMID>16269386</PMID>
  </reference>
  <verification_date>December 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 3, 2008</study_first_submitted>
  <study_first_submitted_qc>January 4, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 7, 2008</study_first_posted>
  <last_update_submitted>January 7, 2008</last_update_submitted>
  <last_update_submitted_qc>January 7, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2008</last_update_posted>
  <responsible_party>
    <name_title>Prof. Guido Torzilli</name_title>
    <organization>University of Milan, Istituto Clinico Humanitas - IRCCS</organization>
  </responsible_party>
  <keyword>intraoperative ultrasonography</keyword>
  <keyword>colorectal liver metastases</keyword>
  <keyword>hepatectomy</keyword>
  <keyword>portal vein embolization</keyword>
  <keyword>Liver</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
    <mesh_term>Neoplasm Metastasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

